Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.
暂无分享,去创建一个
[1] I. Katona,et al. PMP22 expression in dermal nerve myelin from patients with CMT1A. , 2009, Brain : a journal of neurology.
[2] M. Ryan,et al. Neurophysiologic abnormalities in children with Charcot‐Marie‐Tooth disease type 1A , 2008, Journal of the peripheral nervous system : JPNS.
[3] M. Meisler,et al. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. , 2008, Brain : a journal of neurology.
[4] L. Santoro,et al. Myelinated nerve endings in human skin , 2007, Muscle & nerve.
[5] L. Notterpek,et al. Developmental abnormalities in the nerves of peripheral myelin protein 22‐deficient mice , 2007, Journal of neuroscience research.
[6] Yunhong Bai,et al. Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes. , 2006, Archives of neurology.
[7] M. Shy,et al. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B , 2006, Neurology.
[8] Yunhong Bai,et al. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration , 2006, The Journal of comparative neurology.
[9] G. Wendelschafer‐Crabb,et al. Morphological features of nerves in skin biopsies , 2006, Journal of the Neurological Sciences.
[10] A. Murphy,et al. Peripheral Myelin Protein 22 Is in Complex with α6β4 Integrin, and Its Absence Alters the Schwann Cell Basal Lamina , 2006, The Journal of Neuroscience.
[11] A. Schenone,et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. , 2005, Brain : a journal of neurology.
[12] Jun Yu Li,et al. Reliability and validity of the CMT neuropathy score as a measure of disability , 2005, Neurology.
[13] E. Shooter,et al. Enhancement of Schwann cell myelin formation by K252a in the Trembler‐J mouse dorsal root ganglion explant culture , 2005, Journal of neuroscience research.
[14] R. Ribchester,et al. Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves , 2004, Nature.
[15] M. Pericak-Vance,et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A , 2004, Nature Genetics.
[16] Maria Nolano,et al. Quantification of myelinated endings and mechanoreceptors in human digital skin , 2003, Annals of neurology.
[17] J. Perea,et al. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A * , 2002, Journal of anatomy.
[18] S. Scherer,et al. Recent progress on the molecular organization of myelinated axons , 2002, Journal of the peripheral nervous system : JPNS.
[19] P. Brophy,et al. Genetic Dysmyelination Alters the Molecular Architecture of the Nodal Region , 2002, The Journal of Neuroscience.
[20] K. Nave,et al. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot‐Marie‐Tooth disease type 1A , 2002, Journal of neuroscience research.
[21] S. Hinderer,et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.
[22] Jean-Antoine Girault,et al. Axo-Glial Interactions Regulate the Localization of Axonal Paranodal Proteins , 1999, The Journal of cell biology.
[23] P. Edomi,et al. Clinical and pathological correlations in charcot–marie–tooth neuropathy type 1A with the 17p11.2p12 duplication: A cross‐sectional morphometric and immunohistochemical study in twenty cases , 1998, Muscle & nerve.
[24] T. Crawford,et al. Small‐fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases , 1998, Annals of neurology.
[25] Mark Ellisman,et al. Potassium Channel Distribution, Clustering, and Function in Remyelinating Rat Axons , 1998, The Journal of Neuroscience.
[26] A. Harding,et al. The phenotypic manifestations of chromosome 17p11.2 duplication. , 1997, Brain : a journal of neurology.
[27] M. Rydmark,et al. Axoplasmic organelles at nodes of Ranvier. I. Occurrence and distribution in large myelinated spinal root axons of the adult cat , 1993, Journal of neurocytology.
[28] J. Albers,et al. Chronic inflammatory demyelinating polyradiculoneuropathy , 1992, Neurology.
[29] F. Gabreëls,et al. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I) , 1992, Journal of the Neurological Sciences.
[30] F. Baas,et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) , 1991, Neuromuscular Disorders.
[31] E. Shooter,et al. A myelin protein is encoded by the homologue of a growth arrest-specific gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[32] Aravinda Chakravarti,et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.
[33] G. Nicholson,et al. Penetrance of the hereditary motor and sensory neuropathy la mutation , 1991, Neurology.
[34] P. Dyck,et al. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1 , 1989, Neurology.
[35] A. Sumner,et al. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies , 1982, Neurology.
[36] P K Thomas,et al. The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.
[37] P. Dyck,et al. Chronic inflammatory polyradiculoneuropathy. , 1975, Mayo Clinic proceedings.
[38] H. Skre,et al. Genetic and clinical aspects of Charcot‐Marie‐Tooth's disease , 1974, Clinical genetics.
[39] W. Karnes,et al. Histologic and teased-fiber measurements of sural nerve in disorders of lower motor and primary sensory neurons. , 1968, Mayo Clinic proceedings.
[40] R. Winkelmann,et al. Quantitation of Meissner's corpuscles in hereditary neurologic disorders , 1966, Neurology.
[41] N. Meyers,et al. H = W. , 1964, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Murphy,et al. Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] F. Gabreëls,et al. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations , 2004, Acta Neuropathologica.
[44] G. Sobue,et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. , 2003, Brain : a journal of neurology.
[45] I. Marín,et al. The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease , 2002, Nature Genetics.
[46] J. Gilbert,et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 , 2002, Nature Genetics.
[47] J. McArthur,et al. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. , 2001, Diabetes technology & therapeutics.
[48] S. Scherer,et al. On the molecular architecture of myelinated fibers , 2000, Histochemistry and Cell Biology.
[49] R. V. Wetering,et al. Human nerve pathology caused by different mutational mechanisms of the PMP22 gene. , 1999, Annals of the New York Academy of Sciences.
[50] X. Estivill,et al. Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative Study , 1996, European journal of human genetics : EJHG.